ArticleTranslational cancer research2022
Uniportal video-assisted thoracoscopic surgery (VATS) for the treatment of early-stage lung cancer with whole pleural adhesion.
Article in Translational cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- Surgical techniques and outcomes of robot-assisted anatomical lung resection in patients with complete pleural adhesions.General thoracic and cardiovascular surgery · 2026Article
- Comparative outcomes of uniportal and multiportal video-assisted thoracoscopic surgery-a systematic review and meta-analysis.Journal of thoracic disease · 2026Article
- The unified front: a multidisciplinary approach in the Era of uniportal thoracic surgery.Frontiers in surgery · 2026Review
- Long-term outcome of uniport vs. multiport video-assisted thoracoscopic lobectomy for lung cancer.Scientific reports · 2024Article
- [Application and Research Progress of Video Double-lumen Tube in Thoracic Surgery].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Uniportal video-assisted thoracoscopic surgery (VATS) is considered a challenging procedure in cases of lung cancer where the entire pleura and lung are attached (whole pleural adhesion). The purpose of this study was to evaluate the surgical results of uniportal VATS for the treatment of lung cancer with whole pleural adhesion. Methods: For all patients who underwent VATS lung cancer surgery at a single hospital in Korea, multiportal VATS was performed before 2017 and uniportal VATS was performed after January 2017 by the same surgeons. The surgical results of multiportal VATS and uniportal VATS for the treatment of lung cancer with whole pleural adhesion were compared retrospectively. Results: There were 16 eligible uniportal VATS cases and 57 multiportal VATS cases. There were no significant differences of clinicopathologic characteristics between the two groups. There were 5 conversions to open thoracotomy in the multiportal VATS group and no conversion to open thoracotomy in the uniportal group (P=0.579). The perioperative and postoperative outcomes were not different between the two groups. There was no mortality in all patients. For patients undergoing VATS lobectomy, the perioperative and postoperative outcomes were similar after uniportal and multiportal VATS lobectomy. For all patients, the 3-year recurrence-free survival (RFS) was 80.0% after uniportal VATS and 79.5% after multiportal VATS (P=0.951) and for patients with stage I non-small cell lung cancer (NSCLC), the 3-year RFS after uniportal VATS was 91.7% and the 3-year RFS after multiportal VATS was 89.3% (P=0.999). Uniportal VATS was not a significant risk factor for recurrence in the multivariate analysis. Conclusions: Uniportal VATS was not inferior to multiportal VATS in surgical outcome or short-term prognosis in resection of lung cancer with whole pleural adhesion. Whole pleural adhesion is not a contraindication to uniportal VATS, which has been safe and feasible in cases of lung cancer with whole pleural adhesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.